The WADA laboratories will be analyzing for the substances in the program to evaluate patterns of use, but athletes will not incur an anti-doping violation for using substances in the Monitoring Program
People who took GLP-1 drugs for longer experienced progressively greater risk
By activating GLP-1 receptors, semaglutide enhances insulin secretion when blood glucose levels are elevated, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite
Plastic U-100 insulin syringe load Per injection (Fang 2024, PDMS-lubricated plastic syringe, extrapolating from their 1 mL measurement): Full 1 mL stroke: ~10-10 nanoplastic particles from PDMS lubricant alone (plus thousands of microplastics, plus whatever comes off the vial stopper during draw) Typical peptide dose is 0.1-0.3 mL, but scaling isnt linear the stopper-pierce contribution is fixed, and the plunger still travels through PDMS-coated barrel
A clinician may consider glucose patterns, prior hypoglycemia, kidney function, injection burden, other diabetes medicines, pregnancy plans, and the persons ability to use a device correctly
